Multiple Assemblies exist for SMTL entry 6rav
Complement factor B protease domain in complex with the reversible inhibitor 4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid; X-RAY DIFFRACTION 1.70 Å

	SMTL ID 6rav.1 Ligands SULFATE ION; 4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid Polypeptides Complement factor B Oligo-state monomer
	SMTL ID 6rav.2 Ligands SULFATE ION; 4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid; ZINC ION Polypeptides Complement factor B Oligo-state monomer